Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 522Leukemia, Myeloid, Acute 404Leukemia, Myelogenous, Chronic, BCR-ABL Positive 308Leukemia 292Precursor Cell Lymphoblastic Leukemia-Lymphoma 234Myeloproliferative Disorders 210Lymphoma, Non-Hodgkin 167Leukemia, Myelomonocytic, Chronic 156Leukemia, Lymphocytic, Chronic, B-Cell 147Hodgkin Disease 142Primary Myelofibrosis 141Multiple Myeloma 133Leukemia, Myeloid, Chronic-Phase 133Lymphoma 114Leukemia, Myeloid, Accelerated Phase 96Blast Crisis 94Anemia, Refractory, with Excess of Blasts 89Polycythemia Vera 88Lymphoma, Follicular 84Burkitt Lymphoma 81Lymphoma, Mantle-Cell 80Myelodysplastic-Myeloproliferative Diseases 78Lymphoma, B-Cell, Marginal Zone 77Lymphoma, Large B-Cell, Diffuse 73Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 70Congenital Abnormalities 70Neoplasms, Plasma Cell 59Lymphoma, Large-Cell, Immunoblastic 59Thrombocythemia, Essential 57Graft vs Host Disease 57

Interventions

N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hemorrhagic Disorders × Myeloid × Clear all
NCT01998828 2020-04-20

Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

Sierra Oncology LLC - a GSK company

Phase 2 Terminated
39 enrolled
Myeloid

Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, Hematologic Diseases, Hemorrhagic Disorders, Myeloproliferative Disorders, Polycythemia, Polycythemia Vera, Thrombocythemia, Essential, Thrombocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡